Diabetic foot ulcer is an open
sore or wound that occurs in approximately 15 percent of people suffering from
diabetes mellitus. Ulcers can be formed due to combination of factors such as
poor blood circulation, foot deformities, irritation, and prolonged existence
of diabetes. Diabetic foot ulcer can be broadly categorized into five
categories namely neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers, infectious
ulcers, and traumatic ulcers. Diabetic peripheral neuropathy is a precipitating
factor in almost 90% of diabetic foot ulcers. Some of the common medical
approaches which are applicable in prevention of diabetic foot ulcers include
cleaning the wound with mild antiseptic solution, applying antibiotics for
infection management, controlling blood sugar level, undergoing advanced wound
therapies, and surgical interventions. Amoxicillin-clavulanate, Ciprofloxacin,
and Clindamycin are some of the regular antibiotics which are prescribed by
healthcare professional for prevention of diabetic foot ulcer infections. In United
Kingdom, approximately 6000 diabetics undergo amputations of leg, toe, or foot
every year and up to 80 percent of people die within 5 years after amputation.
However, increase in preference for platelet-rich plasma or platelet-rich
fibrin among healthcare professionals in UK are emerging as possible treatment
options for nonhealing ulcers which have thereby reduced the requirement for
amputations. Increasing prevalence of diabetes being a primary cause of
diabetic foot ulcer mainly among population of Scotland, England, Wales, and Northern
Ireland are expected to propel the growth of United Kingdom diabetic foot ulcer
treatment market in the forecast period. Moreover, growing geriatric population
in the region coupled with high instances of diabetic foot ulcers are also
expected to register an impressive growth to the market in forecast period.
Age-related factors such as poor wound healing and reduced blood circulation
are primarily leading to the development of ulcers in elder people. Growing
technological advancements in healthcare system of United Kingdom which mainly
focuses on early curing of diabetic foot ulcer is also a significant factor
behind lucrative growth of United Kingdom diabetic foot ulcer treatment market.
Growing Prevalence of Diabetes
Diabetes is a chronic medical
condition that affects the ability of the body to regulate blood sugar levels. Diabetes
mellitus can lead to the formation of diabetic foot ulcer in people by causing Peripheral
artery disease (PAD) or peripheral neuropathy. Peripheral artery disease (PAD) is more
prominent in the United Kingdom compared to peripheral neuropathy. Some of the
major risk factors which account for proximity of people towards peripheral
artery disease include obesity, smoking, diabetes, and high blood pressure. According
to the report published by Patient UK in 2021, it has been observed that around
4-12% of people above 55-70 years of age get diagnosed with PAD every year.
Moreover, 500-1,000 new cases of critical limb ischemia are reported in United
Kingdom yearly. Ischemic tissue is susceptible to damage and can cause necrosis.
Ulcers that develop in areas of poor blood supply are more likely to aggravate
and develop into non-healing or chronic wounds. Moreover, poor blood
circulation due to PAD inhibits the supply of oxygen and nutrients to the wound
site, which in turn hinders the formation of new blood vessels and the
synthesis of collagen necessary for wound healing. Growing approach of
pharmaceutical products for prevention of diabetic foot ulcer caused by PAD are
influencing the growth of United Kingdom diabetic foot ulcer treatment market
in the forecast period. Antiplatelet medications such as aspirin, clopidogrel,
and ticagrelor helps in formation of blood clots and improves blood flow which
therefore reduces the chances of diabetic foot ulcers. Moreover, availability
of blood sugar control medications in the market such as metformin,
sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose
cotransporter-2 (SGLT2) inhibitors, and insulin which assist in maintaining
target blood sugar levels are also supporting the market growth.
Increase in Geriatric Population
Growing rate of geriatric
population in England, Wales, Southern Ireland, and Scotland is also one of the
predominant factors which supports the growth of United Kingdom diabetic foot
ulcer treatment market in the forecast period. According to the analysis
presented by Statista on ‘The Aging Population of England and Wales’ in 2022,
it has been observed that around 14% of the total population in the countries
were aged between 50-59 years of age, followed by 11% of people between 60-69
years of age, 8% of people were aged between 70-79 years of age, and so on. Symptoms
which are commonly experienced by elder people causing diabetic foot ulcer are
persistent foot pain, inflammation, changes in skin texture, loss of sensation,
slow healing, and others. Among various types of diabetic foot ulcers neurotrophic
ulcers, ischemic ulcers, venous stasis ulcers, and pressure ulcers are some
common ulcers which are found to be more prevalent among elderly people. Medications
commonly used to control blood sugar levels in older adults with diabetes may
include oral antidiabetic drugs (e.g., metformin) or insulin therapy. Moreover,
the growing requirement of nonsteroidal anti-inflammatory drugs (NSAIDs) which
are capable of alleviating discomfort caused by diabetic foot ulcers in older
people is expected to register an impressive growth to United Kingdom diabetic
foot ulcer treatment market in upcoming years.
Download Free Sample Report
Technological Advancements
Growing advancements in treatment
procedures such as advanced wound care products, remote monitoring, negative
pressure wound therapy (NPWT), and hyperbaric oxygen therapy (HBOT) are one of
the emerging significant factors which are leading to the growth of United
Kingdom diabetic foot ulcer treatment market in the forecast period. NPWT
involves the application of a vacuum dressing to the wound site, which helps to
promote healing by removing excess fluid, increasing blood flow, and
stimulating tissue growth. This therapy has shown promising results in treating
diabetic foot ulcers and reducing the need for amputation. Modern development
of new bandage treatment known as a scaffold have evolved as an effective
prevention for diabetic foot ulcers. 3D bio printed scaffolds slowly release
antibiotics over 4 weeks to effectively heal wounds. Moreover, Integra Omnigraft
Dermal Regeneration Matrix (Omnigraft) approved by U.S. Food and Drug
Administration have been a recent addition made to healthcare system for
treatment of diabetic foot ulcers. A matrix device composed of
silicone, bovine collagen, and shark cartilage is placed over the ulcer to
provide an environment for new skin and tissue to regenerate and heal the
wound. Moreover, ongoing research of NO-releasing compounds, such as nitric
oxide-releasing dressings and hydrogels which acquire antimicrobial and
vasodilatory properties for prevention of diabetic foot ulcers is also expected
to drive the growth of United Kingdom diabetic foot ulcer treatment market in
the forecast period.
Recent Developments
- In October
2022, Healthium Medtech introduced the Theruptor Novo wound dressing portfolio
for the treatment of chronic wounds, including diabetic foot ulcers. This
strategy has enabled the company to expand its offering of advanced wound care
products and meet the growing demand for wound care products.
- In January
2022, Smith+Nephew received FDA approval on PICO 7 and PICO 14 Disposable
Negative Pressure Wound Therapy for the treatment of Class I and II wounds,
including traumatic, subacute wounds, burns and diabetic foot ulcers. This
strategy has allowed the company to expand the reach of its products to a large
customer base.
- In July 2018,
Mölnlycke acquired the German wound care company SastoMed GmbH. The aim is to
expand product offerings to help patients and healthcare professionals
accelerate the wound healing process and treatment of chronic wounds such as
diabetic foot ulcers.
United Kingdom diabetic foot
ulcer treatment market is segmented based on treatment, ulcer type, end user, company,
and region. In terms of treatment, the diabetic foot ulcer treatment market is
categorized into wound care dressings, biologics, therapy devices, antibiotic
medications, and others. Based on ulcer type, the United Kingdom diabetic foot
ulcer treatment market is divided into neuropathic ulcers, ischemic ulcers, and
neuroischemic ulcers. Based on end user, diabetic foot ulcer treatment market
is fragmented into hospitals & clinics, ambulatory care centers, and others.
Based on region, the market is segmented into London, East Anglia, Southwest,
Southeast, Scotland, East Midlands, and Yorkshire & Humberside.
Market Players
Medtronic Ltd., 3M United
Kingdom Public Limited, ConvaTec, Inc., Coloplast Ltd., Smith & Nephew plc.,
B. Braun Medical Ltd., Medline Industries Ltd., and Mölnlycke Health Care
Limited are some of the key players in the United Kingdom diabetic foot ulcer
treatment market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2018 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume in tons,
and CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue
forecast, volume forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
Treatment
Ulcer Type
End User
|
|
Regional Scope
|
London, East
Anglia, Southwest, Southeast, Scotland, East Midlands, Yorkshire &
Humberside
|
|
Key Companies Profiled
|
Medtronic Ltd., 3m United Kingdom
Public Limited, ConvaTec, Inc., Coloplast Ltd., Smith & Nephew plc., B.
Braun Medical Ltd., Medline Industries Ltd., Mölnlycke Health Care Limited
|
|
Customization Scope
|
10% free report
customization with purchase. Addition or alteration to country, regional
& segment scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can
also provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United Kingdom diabetic foot ulcer treatment market
has been segmented into following categories, in addition to the industry
trends which have also been detailed below:
- Diabetic
Foot Ulcer Treatment Market, By Treatment:
o Wound Care Dressings
o Biologics
o Therapy Devices
o Antibiotic Medications
o Others
- Diabetic Foot Ulcer Treatment Market, By Ulcer Type:
o
Neuropathic Ulcers
o
Ischemic Ulcers
o
Neuroischemic Ulcers
- Diabetic Foot Ulcer Treatment Market, By Region:
o
London
o
East Anglia
o
Southwest
o
Southeast
o
Scotland
o
East Midlands
o
Yorkshire & Humberside
Competitive Landscape
Company Profiles: Detailed analysis
of the major companies present in United Kingdom diabetic foot ulcer treatment
market.
Available
Customizations:
With
the given market data, TechSci Research offers customizations according to a company’s
specific needs. The following customization options are available for the
report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
United
Kingdom diabetic foot ulcer treatment market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]